ALPS ADVISORS INC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 99 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$105,000
-54.7%
92,332
-10.4%
0.00%
-66.7%
Q4 2021$232,000
-37.6%
103,021
-5.3%
0.00%
-25.0%
Q3 2021$372,000
+6.6%
108,741
-6.9%
0.00%
+33.3%
Q2 2021$349,000
+252.5%
116,761
+84.7%
0.00%
+200.0%
Q3 2016$99,000
+7.6%
63,217
-9.0%
0.00%0.0%
Q2 2016$92,00069,4630.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$7,561,0000.31%
SPHERA FUNDS MANAGEMENT LTD. 1,476,000$1,756,0000.24%
EAM Investors, LLC 840,556$1,000,0000.22%
Gratus Capital, LLC 1,249,248$1,487,0000.16%
Ally Bridge Group (NY) LLC 86,242$103,0000.07%
MARINER INDEPENDENT ADVISOR NETWORK, LLC 1,252,822$1,491,0000.06%
Bleichroeder LP 250,000$298,0000.06%
GSA CAPITAL PARTNERS LLP 324,784$386,0000.05%
Polar Capital Holdings Plc 5,000,000$5,950,0000.04%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$649,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders